Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/23043
Tüm üstveri kaydı
Dublin Core AlanıDeğerDil
dc.date.accessioned2021-12-07T11:11:14Z-
dc.date.available2021-12-07T11:11:14Z-
dc.date.issued2009-04-
dc.identifier.citationYalçın, M. ve Aydın, C. (2009). "Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: Investigation of a peripheral mechanism". Clinical and Experimental Pharmacology and Physiology, 36(4), 447-453.en_US
dc.identifier.issn1440-1681-
dc.identifier.urihttps://doi.org/10.1111/j.1440-1681.2008.05087.x-
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/j.1440-1681.2008.05087.x-
dc.identifier.urihttp://hdl.handle.net/11452/23043-
dc.description.abstract1. The aims of the present study were to determine the cardiovascular effects of arachidonic acid (AA) and to investigate the peripheral mechanisms mediating these effects in haemorrhage-induced hypotensive rats. 2. Acute haemorrhage was induced by withdrawing a total volume of 2.2 mL blood/100 g bodyweight over a period of 10 min. Rats were then injected with 75-300 mu g, i.c.v., AA and cardiovascular changes were monitored over the next 60 min. Plasma catecholamine and vasopressin levels, as well as plasma renin activity (PRA), were measured 10 min after injection of 150 mu g AA in haemorrhage-induced hypotensive awake rats. In addition, rats were pretreated with saline (1 mL/kg, i.v.), the vasopressin V-1 receptor antagonist [beta-mercapto-beta,beta-cyclopentamethylenepropionyl(1),O-Me-Tyr(2),Arg(8)]-vasopressin (10 mu g/kg, i.v.), the alpha(1)-adrenoceptor antagonist prazosin (500 mu g/kg, i.v.), the non-specific angiotensin II receptor antagonist saralasin (250 mu g/kg, i.v.) or a combination of these three antagonists 5 min before injection of AA (150 mu g, i.c.v.). The effects of these antagonists on responses to AA were determined. 3. Arachidonic acid caused dose- and time-dependent increases in mean arterial pressure and heart rate and reversed hypotension in haemorrhaged rats. Haemorrhage itself produced an increase in plasma catecholamine and vasopressin levels, as well as PRA; injection of AA produced further increases in these parameters, ranging from 39-123%, under hypotensive conditions. Under hypotensive conditions, pretreatment of rats with all three receptor antagonists produced similar partial blockade of the pressor response to AA, but not the increase in heart rate. Moreover, combined administration of all three receptor antagonists prior to the i.c.v. injection of 150 mu g AA completely abolished the pressor response to AA in haemorrhage-induced hypotensive rats. 4. These results indicate that centrally administered AA reverses hypotension by increasing blood pressure and heart rate in the hypotensive setting. The observed increases in plasma catecholamine and vasopressin levels, as well as PRA, mediate the pressor response to AA in haemorrhage-induced hypotensive rats.en_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAlpha (1)-adrenoreceptoren_US
dc.subjectAngiotensin II receptorsen_US
dc.subjectArachidonic aciden_US
dc.subjectCatecholamineen_US
dc.subjectHypotensionen_US
dc.subjectIntracerebroventricularen_US
dc.subjectRenin activityen_US
dc.subjectV 1 receptorsen_US
dc.subjectVasopressinen_US
dc.subjectSympatho-adrenomedullary outflowen_US
dc.subjectCentral cholinergic systemen_US
dc.subjectNormotensive conscious ratsen_US
dc.subjectBlood-flow autoregulationen_US
dc.subjectThromboxane a2 analogen_US
dc.subjectNewborn pigsen_US
dc.subjectVasopressin secretionen_US
dc.subjectCerebral-circulationen_US
dc.subjectInjected u-46619en_US
dc.subjectActivationen_US
dc.subjectPharmacology & pharmacyen_US
dc.subjectPhysiologyen_US
dc.subject.meshAdrenergic alpha-1 receptor antagonistsen_US
dc.subject.meshAngiotensin receptor antagonistsen_US
dc.subject.meshAnimalsen_US
dc.subject.meshArachidonic aciden_US
dc.subject.meshBlood pressureen_US
dc.subject.meshCardiovascular systemen_US
dc.subject.meshCatecholaminesen_US
dc.subject.meshConsciousnessen_US
dc.subject.meshDrug evaluation, preclinicalen_US
dc.subject.meshHeart rateen_US
dc.subject.meshHemorrhageen_US
dc.subject.meshHormone antagonistsen_US
dc.subject.meshHypotensionen_US
dc.subject.meshInjections, intraventricularen_US
dc.subject.meshMaleen_US
dc.subject.meshRatsen_US
dc.subject.meshRats, sprague-dawleyen_US
dc.subject.meshReceptors, vasopressinen_US
dc.subject.meshSignal transductionen_US
dc.subject.meshVasopressinsen_US
dc.titleCardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: Investigation of a peripheral mechanismen_US
dc.typeArticleen_US
dc.identifier.wos000265549100015tr_TR
dc.identifier.scopus2-s2.0-68849095950tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Veteriner Fakültesi/Fizyoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-5600-8162tr_TR
dc.contributor.orcid0000-0002-3090-0099tr_TR
dc.identifier.startpage447tr_TR
dc.identifier.endpage453tr_TR
dc.identifier.volume36tr_TR
dc.identifier.issue4tr_TR
dc.relation.journalClinical and Experimental Pharmacology and Physiologyen_US
dc.contributor.buuauthorYalçın, Murat-
dc.contributor.buuauthorAydın, Cenk-
dc.contributor.researcheridAAG-6956-2021tr_TR
dc.identifier.pubmed19702598tr_TR
dc.subject.wosPharmacology & pharmacyen_US
dc.subject.wosPhysiologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ3en_US
dc.contributor.scopusid57192959734tr_TR
dc.contributor.scopusid7005426982tr_TR
dc.subject.scopusHistamine H4 Receptors; Thioperamide; Chlorpheniramine Maleateen_US
dc.subject.emtreeAdrenalinen_US
dc.subject.emtreeAlpha 1 adrenergic receptor blocking agenten_US
dc.subject.emtreeAngiotensin 2 receptor antagonisten_US
dc.subject.emtreeArachidonic aciden_US
dc.subject.emtreeArgipressin[1 (3,3 cyclopentamethylene 3 mercaptopropionic acid) 2 (o methyltyrosine)]en_US
dc.subject.emtreeCatecholamineen_US
dc.subject.emtreeNoradrenalinen_US
dc.subject.emtreePrazosinen_US
dc.subject.emtreeSaralasinen_US
dc.subject.emtreeVasopressinen_US
dc.subject.emtreeAdrenalin blood levelen_US
dc.subject.emtreeAnimal experimenten_US
dc.subject.emtreeAnimal modelen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCardiovascular effecten_US
dc.subject.emtreeCatecholamine blood levelen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDose responseen_US
dc.subject.emtreeHeart rateen_US
dc.subject.emtreeHemorrhagic shocken_US
dc.subject.emtreeHypotensionen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMean arterial pressureen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreeNoradrenalin blood levelen_US
dc.subject.emtreePlasma renin activityen_US
dc.subject.emtreePressor responseen_US
dc.subject.emtreeRaten_US
dc.subject.emtreeVasopressin blood levelen_US
dc.subject.emtreeStatistical analysisen_US
Koleksiyonlarda Görünür:Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.